Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review

The reduction in infectious disease morbidity and mortality may be attributed to a variety of factors; however, improved sanitation and public health, and the introduction of vaccines and antibiotics are among the most significant. The development of antimicrobial resistance (AMR) in bacterial patho...

Full description

Bibliographic Details
Main Authors: Márió Gajdács, Edit Urbán, Anette Stájer, Zoltán Baráth
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:European Journal of Investigation in Health, Psychology and Education
Subjects:
Online Access:https://www.mdpi.com/2254-9625/11/1/6
_version_ 1797409937078353920
author Márió Gajdács
Edit Urbán
Anette Stájer
Zoltán Baráth
author_facet Márió Gajdács
Edit Urbán
Anette Stájer
Zoltán Baráth
author_sort Márió Gajdács
collection DOAJ
description The reduction in infectious disease morbidity and mortality may be attributed to a variety of factors; however, improved sanitation and public health, and the introduction of vaccines and antibiotics are among the most significant. The development of antimicrobial resistance (AMR) in bacterial pathogens is an expected consequence of evolutionary adaptation to these noxious agents and the widespread use of these drugs has significantly sped up this process. Infections caused by multidrug resistant pathogens are directly associated with worse clinical outcomes, longer hospital stays, excess mortality in the affected patients and an increasing burden and costs on the healthcare infrastructure. The Sustainable Development Goals (SDGs) were published in 2015 by the United Nations to serve as a global blueprint for a better, more equitable, more sustainable life on our planet. The SDGs contextualize AMR as a global public health and societal issue; in addition, the continuing emergence of AMR may limit the attainment on many SDGs. The aim of this mini-review is to provide insight on the interface between attainment of SDGs and the clinical problem of drug resistance in bacteria.
first_indexed 2024-03-09T04:22:43Z
format Article
id doaj.art-31461d797ca0409787594fbbf48f9178
institution Directory Open Access Journal
issn 2174-8144
2254-9625
language English
last_indexed 2024-03-09T04:22:43Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series European Journal of Investigation in Health, Psychology and Education
spelling doaj.art-31461d797ca0409787594fbbf48f91782023-12-03T13:44:58ZengMDPI AGEuropean Journal of Investigation in Health, Psychology and Education2174-81442254-96252021-01-01111718210.3390/ejihpe11010006Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief ReviewMárió Gajdács0Edit Urbán1Anette Stájer2Zoltán Baráth3Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös utca 6., 6720 Szeged, HungaryDepartment of Medical Microbiology and Immunology, University of Pécs Medical School, Szigeti út 12., 7624 Pécs, HungaryDepartment of Periodontology, Faculty of Dentistry, University of Szeged, Tisza Lajos körút 62–64., 6720 Szeged, HungaryDepartment of Prosthodontics, Faculty of Dentistry, University of Szeged, Tisza Lajos körút 62-64., 6720 Szeged, HungaryThe reduction in infectious disease morbidity and mortality may be attributed to a variety of factors; however, improved sanitation and public health, and the introduction of vaccines and antibiotics are among the most significant. The development of antimicrobial resistance (AMR) in bacterial pathogens is an expected consequence of evolutionary adaptation to these noxious agents and the widespread use of these drugs has significantly sped up this process. Infections caused by multidrug resistant pathogens are directly associated with worse clinical outcomes, longer hospital stays, excess mortality in the affected patients and an increasing burden and costs on the healthcare infrastructure. The Sustainable Development Goals (SDGs) were published in 2015 by the United Nations to serve as a global blueprint for a better, more equitable, more sustainable life on our planet. The SDGs contextualize AMR as a global public health and societal issue; in addition, the continuing emergence of AMR may limit the attainment on many SDGs. The aim of this mini-review is to provide insight on the interface between attainment of SDGs and the clinical problem of drug resistance in bacteria.https://www.mdpi.com/2254-9625/11/1/6antibioticsantibiotic resistanceMDRSustainable Development Goals (SDGs)povertyglobal health
spellingShingle Márió Gajdács
Edit Urbán
Anette Stájer
Zoltán Baráth
Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
European Journal of Investigation in Health, Psychology and Education
antibiotics
antibiotic resistance
MDR
Sustainable Development Goals (SDGs)
poverty
global health
title Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
title_full Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
title_fullStr Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
title_full_unstemmed Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
title_short Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
title_sort antimicrobial resistance in the context of the sustainable development goals a brief review
topic antibiotics
antibiotic resistance
MDR
Sustainable Development Goals (SDGs)
poverty
global health
url https://www.mdpi.com/2254-9625/11/1/6
work_keys_str_mv AT mariogajdacs antimicrobialresistanceinthecontextofthesustainabledevelopmentgoalsabriefreview
AT editurban antimicrobialresistanceinthecontextofthesustainabledevelopmentgoalsabriefreview
AT anettestajer antimicrobialresistanceinthecontextofthesustainabledevelopmentgoalsabriefreview
AT zoltanbarath antimicrobialresistanceinthecontextofthesustainabledevelopmentgoalsabriefreview